, Malitz (1966) and Shepherd et al.
(ig68).
On the other hand, Gander (1965 Gander ( , 1967 , Sargant (1963 Sargant ( , 1965 Sargant ( , 1966 Sargant ( , 1967 Sargant ( , 1969 Pare (1965) , Hall (1965) , Winston (i@7i), Ayd (ig7i) and Watts (1964) have shown that this drug regimen can be very effective, especially in refractory casesofdepression, and quitesafe when given under certain conditions and with due precautions.
It would be incorrect to attribute serious adverse reactions to the therapeutic use of combined antidepressants on thebasis ofreports inwhich adverse reactions were due toeither the taking of an overdose of combined antide pressants, or to the concurrent use of significant amounts of other drugs acting on the central nervous system (CNS) with combined anti depressants.
On reviewing the literature on the dangers of combining antidepressants, seven reports were found (Babiak, 1961; Ciocatto et al., 1972; Davies, 1960; Jarecid, 1963; Lee, 1961; Luby ci al., 1961; Stanley ci a!., 1964) 
in which taking
an overdose of combined antidepressants with suicidal intention was responsible for severe reaction or fatality; and in nine other reports (Bowen, 1964; Chappell, 1966; Grantham ci a!., 1964; Hills, 1965; Hynes, 1965 (â€˜967) have warned @gainst the dangerof sudden introduction of tricydic antidepressants to patients whose levels of serotonin and nor adrenaline in the brain cells have been consider ably raised by the inhibition of the enzyme monoamine oxidase through prior administra tion of MAOIs. Dangerous reactions are less likely to occur when the two types of anti depressants are given concomitantly rather than sequentially (Lancet, 1965; Harrer, 1961 ).
An additionalfatality reported by Sargant MAOIs are thought to act by raising the level of biogenic anunes in the brain cells by inhibiting monoamine oxidase, the main enzyme responsible for their catabolism. On the other hand the tricycic antidepressants act by causing a localized increase in active noradrenaline at the receptor site by inhibiting its reabsorption into the nerve cells, the process by which 95 per cent of noradrenaline is normally inactivated.
Becauseofthedifferences in themode ofaction of the two groups of antidepressants, the theore tical possibility of synergism exists and provides the rationale for combined antidepressant therapy.
It is well recognized that some patients respond to one group of antidepressants and not to the other, and this again could be due to the differences in their mode of action. There are patients who fail to respond to either group of antidepressants and they alsoat timeseither respond poorly to ECT or consistently relapse after a short time. The aims of the present project were to make a close study of such patients in order to determine the kind of depressive illness which fails to respond to antidepressants of either group used alone or to ECT, and to systematically evaluate their response to a combination of antidepressants.
SAMPLE AND METHOD
The patients considered for the trial were those suffering from a depressive illness, who had either failed to respond or consistently who had also failed to respond to either group of antidepressants, and had not been given ECT becauseof her poor physical condition. An additional reason for this patient's inclusion was the reputation of combined antidepressant therapy for causing excessive weight gain; she had failed to gain weight with the usual treat ments for anorexia nervosa, such as high doses of chlorpromazine, etc. The patients included in the trial comprised three males and nine females. Their ages ranged from 20 to 58 years(mean 40'75 years,S.D.
ii â€˜¿ oi). The duration of their current illness ranged from 3 to 36 months (mean i6 months, S.D. ii.i8), and the total number of previous breakdowns among these patients was 28.
Besides all the patients having had treatment with both groups of antidepressants, they had had between them 20 courses of ECT (each course of approximately 6 ECTs); and four of them had been treated with bi-weckly sessions of group psychotherapy over periods ranging from 4 to i i months. Nine out of the 12 patients had I 7 first degree and second degree relatives who suffered from mental illness.
The patients were treated with a combination of phenelzine and amitriptyline after being off all antidepressants for two weeks. All the patients were given phenelzine 15 mg. three times a day and anutriptyline 75 mg. at bedtime, with the exception of two (cases 6 and 12) who had amitriptyline 50 mg., which for them was considered an adequate dose. A few patients also received, for short periods, diazepam or nitrazepam, particularly as night sedation, when they were considered to require such additional medication. Assessment of patients was carried out by Hamilton Rating Scales for depression and anxiety before the start of the treatment and at the end of three and six weeks. A detailed report of all side effects was also kept.
RESULTS
The results are presented in three sections according to the following threefold aims of this project: (a) to determine the nature of the depressive illness among patients who had failed to respond to antidepressants of either group when used singly, or to ECfl'; (b) to systematic allyevaluatethe responseof thesepatients to a combination of amitriptyline and pheneizine; and (c) to make a close study of the adverse reactions to this combination of antidepressants.
(a) The nature of depressive illness that proved refrac tory to treatment by MAOIs, iricyclic antidipressants and ECT A close study was made of the nature of the patients' depressive illness which proved re fractory to antidepressants of either group used alone or to ECT. It was found that none of them suffered from what one would call a typical â€˜¿ endogenous' or â€˜¿ psychotic'depression. Their symptomatology differed in the following ways. All of them showed considerable overt anxiety, and many of them feared being left on their own. Early morning waking was not the predominant feature of their sleep disturbance, except in Case 7. They did not suffer from diurnal varia tion of mood or from appreciable weight loss, except for case i 2. Their mood was influenced by changes in their life circumstances and in their environment. At no time did the patients suffer from depressive delusions or hallucina tions, nor did they express self-depreciatory ideas; and they had never suffered from a manic illness.
Another important way in which they differed from patients suffering from endogenous de pression was that none of them had experienced distinct depressive episodes with symptom-free intervening periods. On the contrary, they showed continuous morbidity with periods of more marked depression and anxiety. To ascer tain the possible length of their morbidity, a record of the number of years from the first breakdown was made, and this showed that this period varied from 0 to 25 years (mean 11.33, standard deviation 8.4).
Another important finding was the occur rence of fairly marked neurotic or personality disorder in nearly all the patients. Patients 2,4, 10 and i i were for years considerably disabled with obsessive-compulsive neurosis; patients i and 9 showed strong hysterical features; patient 3 was a life-long hypochondriac;
and patients i, 4, @, 6, 7 and ii had troublesome phobic symptoms, the last being severely disabled for over seven years by her phobias relating to death.
(b) Evaluation of combinedantidepressant iherapy
The patients were assessed by Hamilton
Rating Scales for both anxiety and depression, as anxiety was associated with depression in all the patients. The ratings were done before starting the treatment, and at the end of three and six weeks. Friedman analysis of variance, as described by S. Siegel (1956) , was used in the statistical analysis of the results, and these are presented in Table I . In this method of statistical analysis the mean ranks are obtained by first ranking each patient's preference for weeks 0, 3 and 6 according to his Hamilton rating for each item, so that the higher the Hamilton score (the worse the patient's condi tion), the lower the ranking and the lower the Hamilton score (the better the patient's condi tion) the higher the ranking. The mean ranks for each item are obtained by averaging all the patients' rankings at weeks 0,3 and 6. Thus, if all the patients improve successively in the assess ments carried out at the beginning and at the end of three and six weeks the mean ranks would be I, 2, 3. However, if no change is noted in the three assessments, the mean ranks would be 2, 2, 2, as in fact occurs in the item â€˜¿ loss of insight'.
From the mean ranks the value of chi-squared is calculated to determine the statistical signifi cance of the changes in each item. As can be seen from Table I , in 22 out of the 32 items the level of statistical significance was 5 per cent or better. The improvement, both in depression and anxiety, as judged by the rating scales and the overall clinical impression was most striking. The patients' comments on their improvement were equally enthusiastic, two of them claiming it to be â€˜¿ the best treatment' they had had for their condition. Improvement in the phobic symptoms was slow to occur, most of it taking place after the six weeks assessment period, but ultimately it was comparable to that of de pression and anxiety.
Subsequentprogress: The duration of the follow up ranged from seven to twenty-four months (mean i6 months). At the time of writing, cases 2, 3, 4, 5, 6, 9, 10, i i and 12 were practically free of depression or anxiety and had resumed their original work or household responsibilities. Case 2, a methods engineer, has been offered promotion to an executive position, and Case 5
Hamilton rating scoresMeanranks at week(@2( has been working for some months after having been unable to do so for over four years. Cases 2, 4, 5, 10 and 12 are still being main tained on smaller doses of combined anti depressants, Cases 3 and 9 on aniitriptyline alone, and Cases 6 and i i have been off combined antidepressants altogether. Case 8, who responded very well, was taken off the combined antidepressants, but after some time she showed signsof recurrence, largely because of serious marital difficulties; she has now been put back on combined antidepressants which probably should not have been stopped as soon as they were. Case i had recurrent fainting attacks and for that reason combined antidepressants had to be stopped. Because of the return of his symptoms he had the operation of stereotactic tractotomy to which he responded T@aIE I
Results
Sâ€"Significant at 5 per cent level or better. NSâ€"Not significant.
Chi-squared hastwo degrees offreedomthroughout. Friedman analysis of variance was used in the statistical analysis as given in S. Siegel, Xon-parametric response initially, improved considerably over the months, but recently he has relapsed, in spite of still being on combined antidepressants, and has had to be re-admitted.
(c) Side-effects
The side-effects experienced by the patients and their severity are presented in Table II . On the whole they were no greater than those experienced with both types of antidepressants used singly. Certain side-effects require further comment.
Recurrent fainting attacks occurred in Case i, but they were equally troublesome when he was on MAOI alone. Occurrence of paraesthesia in six cases, and ulcers in the mouth in five cases, was surprisingly high. However, these side effects were very mild indeed and probably would have not been mentioned if the patients had not been repeatedly asked about them.
â€˜¿ Toxicpsychokinetic reaction' occurred in Case 3 about ten weeks after the commencement of combined antidepressants, and in Case 9
after sixteen weeks but in a very mild form. This reaction has been described by Ayd (1961) in patients treated with MAO inhibitors. Though the reaction superficially resembles a manic state, it is really more like the excitatory state produced by stimulants such as ampheta mine. The salient features are: (a) no prior history of elation or excitement;
(b) clinical condition of excitement.with overactivity rather thanoftrueelation; (c)some degreeofâ€˜¿ toxicity' which at times appears as a confusional state, and (d) much more prompt recovery on stopping the medication than is usually the case in hypomania or mania. In Case 3 this reaction cleared within three or four days of replacing the antidepressants by chlopromazine, and in Case g on stopping phenelzine but continuing amitriptyline.
Excessive weight gain is the most frequently reported side effect of combined antidepressant therapy, but in this series weight gain was not so Gander ( 1966) and Pare (1965) are of the opinion that amitriptyline is safer than imi pramine for combination with MAOIs. This appears to be the case from the review of the literature on combined antidepressants.
In 20 of the 28 reports on adverse reactions mentioned earlier, imipramine was combined with an MAOI. In four reports (Guilmot ci a!., 1967; Hills, 1965; Lockett ci a!., 1965; Singh, ig6o) severe reaction followed when imipramine was given parenterally to patients already on a MAOI, and it would therefore seem advisable not to give antidepressants parenterally when used in combination (Gander, ig66; Lancei, 1965; Pare, 1965; Winston, 1971 were given imipramine, fatal hyperpyrexia with hyperexcitement occurred in a large proportion of animals. The incidence of such reaction was lower with amitriptyline and absent with trimipramine.
More needs to be known about combined antidepressant therapy before it is recognized as an effective and safe method of treating refractory depressive illnesses, and it is hoped that controlled studies with larger groups of patients will be forthcoming. There is also the need to find out the safest and most effective combination, the reasons for adverse reactions when they occur, and the most effective way of treating them.
Simne@iw
Patients suffering from depressive illnesses which proved refractory to treatment by tricycic antidepressants, MAOIs and ECT were collec ted for a trial on a combination of phenelzine and amitriptyline. The patients who had proved refractory to treatment were all found to be suffering from â€˜¿ neurotic' depression with long weight gain proved to be a problem; for instance Cases 7 and 9 put on I5@5 kg. and I2@7 kg. respectively.
DIscussIoN
The number of patients who proved refractory to both groups of antidepressants and to ECT over a two-year period was far less than expected. Another unexpected finding was that none of the refractory patients suffered from a typical â€˜¿ endogenous' or â€˜¿ psychotic'depression; their condition was what could best be described as â€˜¿ neurotic' depression.
The possible reason for the paucity of cases could be the establishment of a thriving lithium clinic at the hospital about the same time as the starting of the trial. Many cases who would have been referred for this trial were probably being treated by lithium. It is also possible that patients suffering from â€˜¿ psychotic'depression were more often considered for lithium therapy, and this could be the reason why there were no cases of â€˜¿ psychotic' depression among the refractory cases of depression chosen for com bined antidepressant therapy.
The study suggests that combined anti depressant therapy is a very effective form of treatment in refractory cases of depression. Ideally the patients' response to the therapy should have been compared with that of a similar control group. However, in this trial the patients have acted as their own controls, as they had previously failed to benefit, some times over long periods, to a variety of anti depressants of both classes, as well as to ECT.
One would not expect combined anti depressant therapy to have any effect on the underlying neurotic or personality disorders which were so frequently found among the refractory cases of depression in this series. However, it was found that relieving the patients' depression and anxiety enabled them either to resolve or to make better adjustments to their neurotic and personality difficulties. It also made psychotherapy and behaviourtherapypossible when previously the patients were considered intractable by both these forms of treatment. As the resolution of neurotic and personality difficulties usually takes a long time, it is neces sary to protect the patient against relapse by
